ODX On Other Exchanges
Symbol
Exchange
London

omega diagnostics group plc (ODX) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OMEGA DIAGNOSTICS GROUP PLC (ODX)
\

Related News

No related news articles were found.

omega diagnostics group plc (ODX) Related Businessweek News

No Related Businessweek News Found

omega diagnostics group plc (ODX) Details

Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other. The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases. This segment’s principal products include Allergozyme, Allersys, and Genesis Elisa. The Food Intolerance segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Genarrayt/Foodprint name. This segment also provides CNS laboratory services that offer clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Infectious Diseases and Other segment is involved in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. Its principal products comprise Immutrep Syphilis, Micropath bacterial tests, and Avitex latex serology tests. The company offers its products to hospitals, blood banks, clinics, and laboratories through distributors in approximately 100 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.

197 Employees
Last Reported Date: 08/11/18
Founded in 1987

omega diagnostics group plc (ODX) Top Compensated Officers

CEO & Executive Director
Total Annual Compensation: 191.0K GBP
Group Finance Director, Company Secretary & E...
Total Annual Compensation: 159.0K GBP
Commercial Director & Executive Director
Total Annual Compensation: 149.6K GBP
Global Ambassador - Life President
Total Annual Compensation: 317.2K GBP
Compensation as of Fiscal Year 2018.
omega diagnostics group plc
Omega Diagnostics Group plc Provides Revenue Guidance for the Year Ending March 31, 2019

Omega Diagnostics Group PLC provided revenue guidance for the year ending March 31, 2019. For the period the company expects revenue to be £9.76 million.

Omega Diagnostics Group PLC Announces Appointment of Jeremy Millard as Independent Non-Executive Director

Omega Diagnostics Group PLC announced the appointment of Jeremy Millard as Non-Executive Director to the Board with immediate effect, after a thorough search process. The Board consider Jeremy to be independent and it is anticipated that he will, in due course, be appointed to the Audit and Remuneration Committees of the Company. Jeremy has 20 years investment banking experience and was previously a partner at Smith Square Partners LLP where he provided strategic and corporate advice to clients in the science, technology and telecommunications sectors, prior to which he headed up the technology practice at Rothschild in London. Jeremy is currently a Non-Executive Director and chairman of the audit committee of Idox plc and a Non-Executive Director of Ilika Plc.

Omega Diagnostics Group PLC Announces Directorate Changes

Omega Diagnostics Group PLC announced that David Evans, Chairman of the Company, has resigned from the Board and stepped down with immediate effect. Bill Rhodes has agreed to act as interim Chairman. Under David's leadership, the Company had already been in the process of identifying and recruiting an additional Non-Executive Director to further strengthen the Board. During that process, David decided that after 18 years' service, the opportunity to also bring fresh perspective from the position of Chairman would enable the Board to focus on the reshaped business and new opportunities that lie ahead.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

ODX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ODX.
View Industry Companies
 

Industry Analysis

ODX

Industry Average

Valuation ODX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.9x
Price/Book 0.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OMEGA DIAGNOSTICS GROUP PLC, please visit www.omegadiagnostics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.